S&P 500   3,785.38
DOW   30,775.43
QQQ   280.28
S&P 500   3,785.38
DOW   30,775.43
QQQ   280.28
S&P 500   3,785.38
DOW   30,775.43
QQQ   280.28
S&P 500   3,785.38
DOW   30,775.43
QQQ   280.28

Cronos Group Stock Forecast, Price & News

-0.06 (-2.08%)
(As of 06/30/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.52 million shs
Average Volume
2.20 million shs
Market Capitalization
$1.07 billion
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock Forecast (MarketRank)

Overall MarketRank

1.68 out of 5 stars

Medical Sector

940th out of 1,433 stocks

Medicinals & Botanicals Industry

8th out of 23 stocks

Analyst Opinion: 3.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
Cronos Group logo

About Cronos Group (NASDAQ:CRON)

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

CRON Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Medicinals & botanicals
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
8 Analysts


Net Income
$-396.11 million
Pretax Margin


Sales & Book Value

Annual Sales
$74.43 million
Book Value
$3.56 per share


Free Float
Market Cap
$1.07 billion

Cronos Group Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Cronos Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View analyst ratings for Cronos Group
or view top-rated stocks.

What is Cronos Group's stock price forecast for 2022?

8 analysts have issued 1 year price targets for Cronos Group's stock. Their CRON stock forecasts range from $3.00 to $6.00. On average, they predict Cronos Group's share price to reach $4.37 in the next year. This suggests a possible upside of 55.1% from the stock's current price.
View analysts' price targets for Cronos Group
or view top-rated stocks among Wall Street analysts.

How has Cronos Group's stock price performed in 2022?

Cronos Group's stock was trading at $3.92 at the start of the year. Since then, CRON shares have decreased by 28.1% and is now trading at $2.82.
View the best growth stocks for 2022 here

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022.
View our earnings forecast for Cronos Group

How were Cronos Group's earnings last quarter?

Cronos Group Inc. (NASDAQ:CRON) issued its earnings results on Tuesday, May, 10th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.01. The firm earned $25.03 million during the quarter, compared to the consensus estimate of $30.66 million. Cronos Group had a negative net margin of 36.04% and a negative trailing twelve-month return on equity of 15.92%. The business's quarterly revenue was up 98.5% on a year-over-year basis. During the same period in the previous year, the business posted ($0.12) EPS.
View Cronos Group's earnings history

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:
  • Mr. Michael Ryan Gorenstein J.D., Pres, CEO & Chairman (Age 35, Pay $389.15k) (LinkedIn Profile)
  • Mr. Robert L. Madore, Chief Financial Officer (Age 57, Pay $164.42k)
  • Ms. Shannon Buggy, Sr. VP & Global Head of People (Age 52, Pay $438.81k)
  • Ms. Anna Shlimak, Sr. VP of Corp. Affairs & Strategy (Age 36, Pay $422.03k)
  • Mr. Carlos Cortez, VP, Controller & Principal Accounting Officer (Age 49)
  • Mr. Shayne J. Laidlaw, Director of Investor Relations & Strategy
  • Mr. Terry Gregory-Joseph Doucet, Sr. VP of Legal & Regulatory Affairs and Corp. Sec. (Age 32)
  • Mr. Jeffrey David Jacobson, Sr. VP & Head of Growth of North America (Age 36)
  • Mr. Arye Weigensberg, Interim Head of R&D
  • Mr. John Griese, Sr. VP & Head of Operations of North America (Age 60)

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC), Aurora Cannabis (ACB), Tilray (TLRY), (APHA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $2.82.

How much money does Cronos Group make?

Cronos Group (NASDAQ:CRON) has a market capitalization of $1.07 billion and generates $74.43 million in revenue each year. The company earns $-396.11 million in net income (profit) each year or ($0.090010) on an earnings per share basis.

How many employees does Cronos Group have?

Cronos Group employs 626 workers across the globe.

How can I contact Cronos Group?

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The official website for Cronos Group is www.thecronosgroup.com. The company can be reached via phone at (416) 504-0004.

This page (NASDAQ:CRON) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]tbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.